# Calabash Bioscience, Inc.: Form D filing

Calabash Bioscience, Inc., a pharmaceuticals company in College Park, MD, filed a Form D with the SEC in 2015. The latest, on April 24, 2015, reports $250,000 sold of a $250,000 offering to 2 investors.

Find out what Calabash Bioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Calabash%20Bioscience%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Calabash%20Bioscience%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcalabash-bioscience-inc-1640323)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Calabash%20Bioscience%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Calabash%20Bioscience%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcalabash-bioscience-inc-1640323)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 387 TECHNOLOGY DRIVE, SUITE 3119, College Park, MD, 20742
- Phone: (240) 498-2004
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1640323

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 24, 2015 | New notice | $250,000 | $250,000 | $0 | 2 | Apr 16, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1640323/000164032315000001/0001640323-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Lyle David Isaacs | Executive Officer, Director |  |

[Every Form D from the week of Apr 20, 2015](https://specstream.ai/data/form-d/week/2015-04-20) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Calabash Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).